Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-02-01
|
| Series: | World Journal of Surgical Oncology |
| Online Access: | https://doi.org/10.1186/s12957-023-02931-z |
| _version_ | 1827983930344603648 |
|---|---|
| author | Gizem Oner Semen Önder Hüseyin Karatay Naziye Ak Mustafa Tükenmez Mahmut Müslümanoğlu Abdullah İğci Ahmet Dincçağ Vahit Özmen Adnan Aydiner Ekrem Yavuz Neslihan Cabioğlu |
| author_facet | Gizem Oner Semen Önder Hüseyin Karatay Naziye Ak Mustafa Tükenmez Mahmut Müslümanoğlu Abdullah İğci Ahmet Dincçağ Vahit Özmen Adnan Aydiner Ekrem Yavuz Neslihan Cabioğlu |
| author_sort | Gizem Oner |
| collection | DOAJ |
| first_indexed | 2024-04-09T22:54:00Z |
| format | Article |
| id | doaj.art-88a69974f53347d8ba730e28dbb06e93 |
| institution | Directory Open Access Journal |
| issn | 1477-7819 |
| language | English |
| last_indexed | 2024-04-09T22:54:00Z |
| publishDate | 2023-02-01 |
| publisher | BMC |
| record_format | Article |
| series | World Journal of Surgical Oncology |
| spelling | doaj.art-88a69974f53347d8ba730e28dbb06e932023-03-22T11:24:22ZengBMCWorld Journal of Surgical Oncology1477-78192023-02-012111110.1186/s12957-023-02931-zCorrection: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapyGizem Oner0Semen Önder1Hüseyin Karatay2Naziye Ak3Mustafa Tükenmez4Mahmut Müslümanoğlu5Abdullah İğci6Ahmet Dincçağ7Vahit Özmen8Adnan Aydiner9Ekrem Yavuz10Neslihan Cabioğlu11Department of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of Medical Oncology, Institute of Oncology, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of Medical Oncology, Institute of Oncology, Istanbul UniversityDepartment of Pathology, Istanbul Faculty of Medicine, Istanbul UniversityDepartment of General Surgery, Istanbul Faculty of Medicine, Istanbul Universityhttps://doi.org/10.1186/s12957-023-02931-z |
| spellingShingle | Gizem Oner Semen Önder Hüseyin Karatay Naziye Ak Mustafa Tükenmez Mahmut Müslümanoğlu Abdullah İğci Ahmet Dincçağ Vahit Özmen Adnan Aydiner Ekrem Yavuz Neslihan Cabioğlu Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy World Journal of Surgical Oncology |
| title | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_full | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_fullStr | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_full_unstemmed | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_short | Correction: Clinical impact of PD-L1 expression in triple-negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| title_sort | correction clinical impact of pd l1 expression in triple negative breast cancer patients with residual tumor burden after neoadjuvant chemotherapy |
| url | https://doi.org/10.1186/s12957-023-02931-z |
| work_keys_str_mv | AT gizemoner correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT semenonder correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT huseyinkaratay correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT naziyeak correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT mustafatukenmez correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT mahmutmuslumanoglu correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT abdullahigci correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT ahmetdinccag correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT vahitozmen correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT adnanaydiner correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT ekremyavuz correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy AT neslihancabioglu correctionclinicalimpactofpdl1expressionintriplenegativebreastcancerpatientswithresidualtumorburdenafterneoadjuvantchemotherapy |